Anixa Biosciences, Inc.

NASDAQ:ANIX

Biotechnology

Healthcare
$2.71 +3.72%

+$0.10 today

Market cap
$94.21M
Beta
0.60
P/E (TTM)
-9.3
EPS (TTM)
-$0.30
52W Low $2.32High $5.46

Volume 0.29M

Average 0.12M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$11.70M

FY 2025 · Annual

Net Income

-$10.93M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Revenue512K0210K00
Cost of Revenue385K0161K036K
Gross Profit127K049K0(36K)
Gross Margin24.8%—23.3%——
Research & Development6.19M6.7M4.77M6.4M5.07M
Selling, General & Admin7.07M7.17M6.29M7.44M6.63M
Operating Expenses13.26M13.88M11.06M13.83M11.67M
Depreciation & Amortization59.86K42K46K37K36K
EBITDA(13.08M)(13.73M)(9.88M)(12.66M)(10.99M)
EBITDA Margin-2554.9%—-4706.7%——
Operating Income(13.14M)(13.88M)(11.01M)(13.83M)(11.7M)
Operating Margin-2565.6%—-5243.3%——
Interest Income2.32K104K1.08M1.13M673K
Interest Expense322104K000
Other Income / Expenses7.77K104K1.08M1.13M673K
Income Before Tax(13.13M)(13.77M)(9.93M)(12.7M)(11.03M)
Pre-Tax Margin-2564.0%—-4728.6%——
Income Tax Expense00000
Net Income(12.95M)(13.6M)(9.81M)(12.55M)(10.93M)
Net Margin-2528.6%—-4671.9%——
EPS (Basic)(0.45)(0.45)(0.32)(0.39)(0.34)
EPS (Diluted)(0.45)(0.45)(0.32)(0.39)(0.34)
Weighted Avg Shares28.58M30.37M30.98M31.9M32.45M
Weighted Avg Shares (Diluted)28.58M30.37M30.98M31.9M32.45M

ANIX Earnings Waterfall · TTM

NASDAQ:ANIX · Revenue to Net Income

Key Ratios

EPS$-0.30
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-10.8
P/S Ratio0.0

Analysis

$0 of revenue converted into -$10.1M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.30, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipOct 26, 2026
4Statement of changes in beneficial ownershipOct 22, 2026
4Statement of changes in beneficial ownershipSep 30, 2026
4Statement of changes in beneficial ownershipSep 28, 2026

How much revenue does ANIX generate?

Anixa Biosciences, Inc. (ANIX) reported $0.00 of revenue in fiscal 2025.

Is ANIX profitable?

Anixa Biosciences, Inc. (ANIX) reported -$10.93M of net income.